Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06704477 · ClinicalTrials.gov registry record

Dietary Protein Preferences of Adolescent Athletes

A clinical trial of Diet Habit, sponsored by PepsiCo Global R&D.

Completed
Registry status
161
Enrollment target
1
Study location

NCT06704477: Completed study of Diet Habit, sponsored by PepsiCo Global R&D.

NCT06704477 is a study of Diet Habit that has completed, run by PepsiCo Global R&D. The registered enrollment target is 161 participants, below the 11,769-participant average among 22 other Diet Habit trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06704477, a study of Diet Habit, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
161 participants
Enrollment target
1
Study location

Study Summary

This is a survey study to gauge the interest of young athletes ages 12-19 in plant-based protein products. The teen competitive athlete is a core target for the Gatorade brand and, as such, understanding their preferences and what drives their choices is vital for the brand's continued growth.

Primary Outcome

Part of a 10 minute multiple choice survey

Conditions Studied

Interventions

  • OTHER Survey

Study Locations (1)

Florida

  • IMG Academy - Bradenton

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2024-02-22
Est. Completion 2024-10-25
PepsiCo Global R&D

47 total trials

What the finished NCT06704477 record still lists

NCT06704477 is an observational study that tracks outcomes without assigning an intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 11,769-participant average among 22 other Diet Habit trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Diet Habit appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.

NCT06704477 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06704477 about?

NCT06704477 is a clinical study titled "Dietary Protein Preferences of Adolescent Athletes". This is a survey study to gauge the interest of young athletes ages 12-19 in plant-based protein products. The teen competitive athlete is a core target for the Gatorade brand and, as such, understanding their preferences and what drives their choices is vital for the brand's continued growth.

What is the current status of trial NCT06704477?

This trial is currently completed. The enrollment target is 161 participants. The study started on 2024-02-22. Estimated completion is 2024-10-25.

What conditions does trial NCT06704477 study?

This clinical trial studies the following conditions: Diet Habit.

What interventions are being tested in trial NCT06704477?

The interventions under investigation include: Survey (OTHER).

Who is sponsoring clinical trial NCT06704477?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06704477 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diet Habit

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06704477's enrollment target sits among peer trials

161 10th of 22 higher than 13 of 22 other Diet Habit trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diet Habit trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06391034 · 161 participants · Phase 2

    Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

  • NCT06546670 · 161 participants · Phase 1

    A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • NCT06616766 · 161 participants · Phase 1

    A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

  • NCT06752356 · 161 participants · Phase 3

    A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06704477, the US trial registry maintained by the National Library of Medicine. NCT06704477 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.